iRhythm Holdings, Inc. (IRTC) income statement
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/303% above fair value
$94.24−0.63 (-0.66%)
Close on Nov 19, 2026Market cap $3.11BP/E –Yield –
iRhythm Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 71.5%
- Operating margin
- -3.0%
- Net margin
- -1.7%
- Return on equity, FY2025
- -36.6%
Financial strength
- Current ratio
- 3.85
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 125.8%
Valuation
- P/E ratio
- –
- Price to sales
- 3.76
- Price to book
- 16.70
- Dividend yield
- –
See a number that looks wrong?